Cargando…

Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the Caregiver Perspective on Pediatric ADHD survey in Europe

BACKGROUND: Burden on caregivers of children/adolescents with attention-deficit/hyperactivity disorder (ADHD) is multidimensional, but incompletely understood. OBJECTIVE: To analyze caregiver burden across the concepts of work, social/family life, and parental worry/stress, in relation to selected c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fridman, Moshe, Banaschewski, Tobias, Sikirica, Vanja, Quintero, Javier, Erder, M Haim, Chen, Kristina S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308565/ https://www.ncbi.nlm.nih.gov/pubmed/28223810 http://dx.doi.org/10.2147/NDT.S121391

Ejemplares similares

Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey
por: Fridman, Moshe, et al.
Publicado: (2017)

Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control
por: Fridman, Moshe, et al.
Publicado: (2017)

Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers
por: Flood, Emuella, et al.
Publicado: (2016)

Concomitant Pharmacotherapy of Psychotropic Medications in EU Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Sikirica, Vanja, et al.
Publicado: (2013)

Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case
por: Le, Hoa H., et al.
Publicado: (2013)

Comparative Treatment Patterns, Resource Utilization, and Costs in Stimulant-Treated Children with ADHD Who Require Subsequent Pharmacotherapy with Atypical Antipsychotics Versus Non-Antipsychotics
por: Sikirica, Vanja, et al.
Publicado: (2012)

Unmet Needs Associated with Attention-Deficit/Hyperactivity Disorder in Eight European Countries as Reported by Caregivers and Adolescents: Results from Qualitative Research
por: Sikirica, Vanja, et al.
Publicado: (2014)

Management of ADHD in children across Europe: patient demographics, physician characteristics and treatment patterns
por: Hodgkins, Paul, et al.
Publicado: (2013)

The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
por: Bieś, Rafał, et al.
Publicado: (2023)

Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD
por: Lachaine, Jean, et al.
Publicado: (2016)

Quality of Life in Caregivers of ADHD Children and Diabetes Patients
por: Andrade, Elisa Meirelles, et al.
Publicado: (2016)

Comparison of Quality of Life, Productivity, Functioning and Self-Esteem in Adults Diagnosed With ADHD and With Symptomatic ADHD
por: Pawaskar, Manjiri, et al.
Publicado: (2019)

Correlations Between Clinical Trial Outcomes Based on Symptoms, Functional Impairments, and Quality of Life in Children and Adolescents With ADHD
por: Coghill, David R., et al.
Publicado: (2017)

Current issues around the pharmacotherapy of ADHD in children and adults
por: Meijer, Willemijn M., et al.
Publicado: (2009)

Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: a physician perspective
por: Setyawan, Juliana, et al.
Publicado: (2014)

Interpreting the Results of a Retrospective Comparison of Test and Reference Treatments in a Randomized Clinical Trial Setting
por: Fridman, Moshe, et al.
Publicado: (2014)

47.1 CHALLENGES IN PRESCRIBING AND OPTIMIZING PHARMACOTHERAPY IN ADOLESCENTS WITH ADHD DURING COVID-19
por: Newcorn, Jeffrey H.
Publicado: (2021)

5.13 The Experience of Children and Adolescents With ADHD and Their Caregivers During the COVID-19 Pandemic: The UNCOVER Study
por: Thorley, Eileen Mack, et al.
Publicado: (2021)

Health-related quality of life and perceived stress of informal caregivers of children and adolescents with intellectual disabilities and ADHD
por: Dubey, M.J., et al.
Publicado: (2023)

The female side of pharmacotherapy for ADHD—A systematic literature review
por: Kok, Francien M., et al.
Publicado: (2020)

Burden sharing in families to children, adolescents and young adults with ADHD: Analysis of ADHD Helpline in Swedish Clinical Services
por: Renhorn, Elina, et al.
Publicado: (2019)

The Etiological Structure of Cognitive-Neurophysiological Impairments in ADHD in Adolescence and Young Adulthood
por: Michelini, Giorgia, et al.
Publicado: (2018)

The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)
por: Coghill, David, et al.
Publicado: (2021)

Quality of Life Changes during the COVID-19 Pandemic for Caregivers of Children with ADHD and/or ASD
por: Pecor, Keith W., et al.
Publicado: (2021)

Psychometric properties of the Caregiver Strain Questionnaire among Chinese parents of children with ADHD or ASD
por: Yang, Runxu, et al.
Publicado: (2021)

Pharmacotherapy of ADHD in Adults With Autism Spectrum Disorder: Effectiveness and Side Effects
por: Muit, J. J., et al.
Publicado: (2019)

Nationwide Rate of Adult ADHD Diagnosis and Pharmacotherapy from 2015 to 2018
por: Lee, Sang-Min, et al.
Publicado: (2021)

Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
por: Coghill, David R., et al.
Publicado: (2017)

ADHD and Adolescent Athletes
por: Nazeer, Ahsan, et al.
Publicado: (2014)

Autonomic arousal profiles in adolescents and young adults with ADHD as a function of recording context
por: Du Rietz, Ebba, et al.
Publicado: (2019)

Cost Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Stimulant Compared with Stimulant Monotherapy for the Treatment of Attention-Deficit Hyperactivity Disorder in Children and Adolescents
por: Sikirica, Vanja, et al.
Publicado: (2012)

A review of the economic burden of ADHD
por: Matza, Louis S, et al.
Publicado: (2005)

Parent/Caregiver Experiences of a CAMHS ADHD Assessment Pathway: A Qualitative Service Evaluation
por: Kruger, Emily
Publicado: (2023)

The value of cognitive behavioral therapy on quality of life in addition to pharmacotherapy in adults with ADHD
por: Wettstein, R., et al.
Publicado: (2022)

Exploration of the understanding and etiology of ADHD in HIV/AIDS as observed by adolescents with HIV/AIDS, caregivers and health workers- using case vignettes
por: Mpango, Richard Stephen, et al.
Publicado: (2018)

The ADHD Concomitant Difficulties Scale (ADHD-CDS), a Brief Scale to Measure Comorbidity Associated to ADHD
por: Fenollar-Cortés, Javier, et al.
Publicado: (2016)

Secular trends and regional variations in pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents in Germany
por: Akmatov, Manas K., et al.
Publicado: (2021)

Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorder
por: Gajria, Kavita, et al.
Publicado: (2015)

Impact of personality on adherence to and beliefs about ADHD medication, and perceptions of ADHD in adolescents
por: Emilsson, Maria, et al.
Publicado: (2020)

Parental education, ADHD in family and ADHD diagnosis incidence in Finnish children and adolescents
por: Volotinen, L, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_40266fubds2rlhpg8d3ko31l4t